# Correction: Evaluating the pentapharmacological potency of otamixaban against lung cancer CDK2, transferase, oxidoreductase and signalling proteins

**Authors:** Hanadi M. Baeissa, Tahani Bakhsh, Afnan Mohammed Shakoori, Ghadir Sindi, Randa Mohammed Zaki, Mohammad Azhar Kamal, Hadeel A. Alsufyani, Alaa Hamed Habib, Arwa Ishaq A. Khayyat, Misbahuddin Rafeeq, Deeba Shamim Jairajpuri

PMC · DOI: 10.1371/journal.pone.0344592 · PLOS One · 2026-03-09

## Full-text entities

- **Genes:** CDK2 (cyclin dependent kinase 2) [NCBI Gene 1017] {aka CDKN2, p33(CDK2)}
- **Diseases:** lung cancer (MESH:D008175)
- **Chemicals:** otamixaban (MESH:C435830)

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12970878/full.md

## References

1 references — full list in the complete paper: https://tomesphere.com/paper/PMC12970878/full.md

---
Source: https://tomesphere.com/paper/PMC12970878